The major reasons supporting the growth of the cell lysis market are rising research and advancement in the fields of proteomics and genomics as well as the broad bandwidth of infectious illnesses and cancer. The development of the cell lysis market is projected to be supported by developments and grants for cell-based therapeutics. For instance, the worldwide health company Novartis AG reported in May 2022 that the US Food and Drug Administration (FDA) had given accelerated approval for Kymriah (tisagenlecleucel) for the treatment of adult patients who have relapsed or refractory (r/r) follicular lymphoma (FL) following two or more lines of systemic therapy. The only CAR-T cell therapy that is now FDA-approved for use in both adult and paediatric settings is Kymriah, which has three additional indications.
Global Cell Lysis Market is estimated to be valued at US$ 3,781.33 million in 2022 and is expected to exhibit a CAGR of 8.6% during the forecast period (2022-2030).
Leading Companies in the Cell Lysis Industry:
1. Becton
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products to the general public worldwide. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. BD (Becton, Dickinson and Company) a leading global medical technology company, and Magnolia Medical Technologies, Inc., October, 2022 announced a co-exclusive commercial agreement aimed at helping U.S. hospitals reduce blood culture contamination to help improve testing accuracy and ultimately improve clinical outcomes.
2. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. since 1956 offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide.
It has headquarters based in Waltham, Massachusetts. Thermo Fisher Scientific, the world leader in serving science, in the month of December. 2022 announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Applied Biosystems TaqPath Monkeypox/Orthopox Virus DNA Kit
3. Merck KgaA
The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KgaA develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. Merck in December 2022 announced that it is collaborating with Mersana Therapeutic Inc. to discover novel antibody-drug.
4. QIAGEN
35 countries
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company was founded in 1986 and is headquartered in Venlo, the Netherlands. In November, 2022 QIAGEN N.V. announced the launch ofthe monkeypox (MPXV) test for its NeuMoDx automated PCR platform to strengthen surveillance and research.
5. Roche Molecular Systems, Inc.
The company was founded in 1896 and is headquartered in Basel, Switzerland. Roche Holding AG engages in the pharmaceuticals and diagnostics businesses.
6. Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California. Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, June, 2022 announced the launch of EconoFit Low-Pressure Prepacked Chromatography Column Packs to support resin screening experiments in the development of protein purification workflows.
7. Cell Signaling Technology, Inc.
Cell Signaling Technology, Inc.a privately-owned company headquartered in Danvers, Massachusetts, USA. And founded in 1999.
*Definition- Cell lysis is the first step of protein extraction, which is further used for different applications such as enzyme engineering and protein labelling.
